Amino Acid Sequence Analysis of Peptides Containing Modified Amino Acids Using The PPSQ -50 Gradient System

Importance of the Topic

Amino acid sequence analysis of peptides containing modified residues is essential for the development and quality control of peptide therapeutics. Modifications such as acetylation or methylation alter peptide stability, activity, and membrane permeability. Reliable identification of these modifications at both N- and C-termini supports the design of drugs with improved in vivo performance.

Objectives and Overview

This study demonstrates a combined approach for accurate sequencing of synthetic peptides bearing non-natural and post-translational modifications. Edman degradation using the PPSQ-50A gradient protein sequencer provides N-terminal information, while MALDI-ISD measurements on a MALDI-8030 bench-top TOF mass spectrometer deliver complementary mass-based data, including C-terminal residues.

Methodology and Instrumentation

The workflow begins with standard analysis of PTH-amino acid mixtures on the PPSQ-50A system to establish retention times for both natural and modified PTH-derivatives. Subsequent Edman degradation cycles are performed on a polybrene-treated glass fiber disk loaded with the peptide sample. ISD spectra are acquired with minimal sample preparation on a MALDI-ISD capable TOF-MS to confirm sequence assignments that are challenging by Edman alone.

• Protein Sequencer: PPSQ-50A gradient system with Wakopak Wakosil PTH-GR column (250 mm × 2.0 mm)
• Detection: SPD-M30A UV detector at 269 nm with high-sensitivity flow cell
• Mobile phases: PTH-amino acids mobile phase A and B for gradient elution (flow rate 0.3 mL/min, column temperature 35 °C)
• MALDI-TOF MS: MALDI-8030 bench-top linear dual-polarity instrument configured for in-source decay (ISD)

Main Results and Discussion

Retention times for acetyl- and trimethyl-lysine PTH-derivatives were resolved without overlap with natural amino acids. Edman sequencing of a histone H4 fragment [(Lys(Ac)12/16, Lys(Me3)20)–Histone H4 (1–25) labeled with biotin] identified modified residues at positions 12, 16, and 20. C-terminal sequencing by Edman was limited due to biotin label and washout effects. MALDI-ISD spectra provided complementary cleavage patterns, confirming C-terminal identity and full sequence coverage, overcoming Edman degradation limitations.

Benefits and Practical Applications

• Enables reliable identification of non-natural and post-translational modifications in small sample volumes.
• Combines orthogonal data to resolve N- and C-terminal residues in peptides not present in databases.
• Supports development and QC of synthetic peptide drugs with enhanced stability and specificity.

Future Trends and Applications

As peptide therapeutics increasingly incorporate modified and cyclic structures to improve bioactivity and stability, integrated sequencing and mass spectrometry workflows will become vital. High-throughput platforms may emerge to analyze diverse modifications, facilitating rapid candidate screening and regulatory compliance in pharmaceutical development.

Conclusion

The combined use of PPSQ-50A Edman sequencing and MALDI-ISD mass spectrometry provides a robust strategy for comprehensive amino acid sequence analysis of modified peptides. This approach addresses the challenges of terminal residue identification and modification mapping, enhancing analytical capabilities for peptide drug research.